Article and Video CATEGORIES

Cancer Journey

Search By

SBRT for Medically Inoperable Stage I Lung Cancer
Mon, 02/01/2016 - 06:00
Author
GRACE Videos and Articles
GRACE Cancer Video Library - Lung

GCVL_LU-D08_SBRT_Medically_Inoperable_Stage_I_Lung_Cancer

 

Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the history and current use of stereotactic radiation therapy for inoperable lung lesions.

 

Download Transcript

 

Transcript

The classic example of the use of stereotactic radiation therapy in the body is for lesions of the lung. This technology started in the 1990s in Japan and in Germany where they were giving five or fewer fractions of radiation therapy to a solitary nodule in the lung in a patient who couldn’t have surgery because they had underlying problems like heart disease or lung disease that wouldn’t allow the patient to have surgery. So they were giving, let’s say 15 gray doses, up to 20 gray doses, in three fractions, to eradicate these tumors in the lung.

That spread to the United States in the 2000s, and it’s a very common treatment today for patients who have been evaluated for surgery but can’t have surgery, usually because their pulmonary function is too low. This technique is very effective, the local control of eradicating that lesion is better than 90%, and 95% in some series. It’s stood the test of time, results are available at five years, giving a good indication that it’s probably equivalent to surgery in the population that’s high risk.

A very controversial area today, are patients who are operable candidates for stereotactic body radiation therapy, and that’s the next topic.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Spanish Targeted Therapy Lung Cancer Patient Forum 2023
Video
2023 Terapias Dirigidas en el Foro de Pacientes con Cáncer de Pulmón El vídeo completo sin editar está disponible On Demand   View HERE  
Image
Spanish TTF 2023
Article
Únete a nosotros, sábado 12 de agosto a las 9:00 a.m.  En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras.  
Image
Targeted Therapies in Lung Cancer Patient Forum 2023
Article
Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum! The full unedited versions of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage and Second Stage, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks.  

Forum Discussions

Hi, I'm sorry you're having these issues.  The type of shoulder pain that feels like nerve pain is most likely nerve pain.  The type of tumor that causes similar shoulder pain...

Thank you so much for the response! I have seen a lot of your post on here and it's really awesome of you to take the time to reply to all...

ONKTALK is tomorrow. 

I hope to see you there.

The forum is now available on demand here.  Don't hesitate to ask questions as they come up. 

Take care,

Janine

Hi happybluesun,  Welcome to Grace.   I'm sorry your mom is going through this. 

 

Driver mutations are mutations that drive (or cause) the cancer.  Having more than one driver mutation is...

Hi Janine, thank you very much for your reply. As of June 2023, my mom has been prescribed Almonertibi Mesilate Tablet, a targeted therapy medicine made by the Chinese company Haosen...

Recent Comments

JOIN THE CONVERSATION
Thank you so much for the…
By Worried472 on Tue, 09/26/2023 - 12:44
Hi, I'm sorry you're having…
By JanineT GRACE … on Tue, 09/26/2023 - 11:24
The forum is now available…
By JanineT GRACE … on Mon, 09/25/2023 - 14:10
Reminder
By JanineT GRACE … on Fri, 09/22/2023 - 15:50